Bionor Pharma ASA - Mandatory notification of trade

| Source: Solon Eiendom ASA Solon Eiendom ASA

Bionor Pharma ASA - Mandatory notification of trade - Lars H Høie

BIONOR PHARMA

STOCK EXCHANGE ANNOUNCEMENT

Reference is made to the announcement by Bionor Pharma ASA on 14 December 2016 regarding completion of EGM.

Upon issuance of the Consideration Shares, the shares in the Private Placement and the shares in the Subsequent Offering, Lars H. Høie will hold 128,973,522 shares and votes in the Company, corresponding to 1.33% of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.

Attachments

Bionor_SEA20161215_MandatoryNotificationOfTrade_Hoie